Jia et al. [111] concluded that metformin might even have a beneficial effect when given post-stroke as it stimulated adenosine monophosphate (AMP)-activated protein kinase (AMPK) and alleviated stroke-enhanced serum glucose levels. This evidence concerns the gene WEE1 and stroke disorder.